Member Info for Deco67

Excellent..So basically they're getting the funding for the Hvivo trial..No matter what happens Hvivo gets paid

Milestone-Based Warrants (Up to $21 Million Additional)The bulk of the capital is locked behind clinical and regulatory achievements. Decoy will only get the extra cash if they successfully hit these exact markers:

Series A Warrants (+$3.5 Million): Triggers once Decoy files its official Clinical Trial Application (CTA) in the European Economic Area to start Phase 1 trials.

Series B Warrants (+$7.0 Million): Triggers upon receiving formal regulatory approval from the UK's MHRA to explicitly begin the Phase 2a human challenge trials.

Series C Warrants (+$7.0 Million): Triggers once they publicly release positive data from those UK Phase 2a trials

Another stop loss taken out at 6.95p..200d MA is gone ,who knows where the next support is..

And another sucker roped in and yes I'm including myself. 😬

Interesting 1.4 million at 7.22p..

This isn't a double blinded trial so we'll know quickly.

Rsi Just over 35..it should be bouncing but im not testing that theory.

What a piece of 💩 this share really is!!

200 😬🙄

50 day MA taken out..can it bounce..doesn't look like it!!

Not a buyer in sight,from the looks of it the seller is just hammering stop losses..

50 day moving average has been broken now i guess its down to test the 200 day..

what a piece of ****e with the markets breaking records daily!

Volumes are low but there's absolutely no appetite for shares..

Capital markets day obviously was a fart in the wind and yet Mo and Steve pocket massive bonuses.

I sure hope Hvivo aren't paying for this useless equity research reports!!!

Interesting all blue chip and then Hvivo..🤔

Good luck

Jester never fall in love with 1 stock..

The markets are rallying all over the world and are at all time highs..on the other hand Hvivo is closer to an all time low..Its probably undervalued but Hvivo is where it is for a reason..

So u have multiple aliases that's nothing to brag about

So now we know Stanley is Moniman (aka muchodinero) in reincarnated. .

What a nice person he was..lol

Sorry man u got caught in a lie..Moniman sold POLB right after the lockup period ended and that was about where it is currently trading

Yes,apparently that was because ConserV Bioscience maintained a much broader pipeline of independent assets that Imutex had absolutely no right to or financial stake in..

hVIVO held a 49% indirect stake in Imutex Limited. Therefore, hVIVO essentially had a 49% stake only in the FLU-v and AGS-v programs.None of the other active projects listed—such as the UNICOR-v pan-coronavirus vaccine, the HIV program, or the Chagas disease targets—were ever part of Imutex. They belonged strictly to ConserV Bioscience’s independent, proprietary pipeline.By restructuring the deal and swapping its 49% share of Imutex for a 10% direct share capital holding in ConserV Bioscience, hVIVO successfully traded away its high concentration in just two assets to get a smaller piece of all 10 vaccine programs ConserV is currently working on.Would you like to know more about the clinical trial timelines for either FLU-v or AGS-v, or should we look at how hVIVO’s financial reports reflected this equity shift?AI responses may include mistakes. Learn morehVIVO (DB:CRO) - Earnings & Revenue Performance - Simply Wall StSimply Wall StreetPoolbeg Pharma Share Chat. Chat About POLB Shares - London South EastLondon South EastThe UK's favourite investor portal.

I remember moniman and I clearly remember him selling POLB when the lockup period ended and that was well below 10p Stanley..

I also remember that you were a fierce defender of Cathal Friel and I mean rampant!

Perhaps some were expecting a contract to coincide with the CMD.

We'll see it'll be on podcast soon enough.

U wud think Ricky..As I said earlier I hope Mo has been above board with investors on that Iliad contract..

Nope I'm long like the rest of ye😒